Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles

被引:82
|
作者
Cassidy, Pamela B.
Edes, Kornelia
Nelson, Chad C.
Parsawar, Krishna
Fitzpatrick, F. A.
Moos, Philip J.
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[4] Univ Utah, Mass Spectrometry & Proteom Core Facil, Salt Lake City, UT 84112 USA
关键词
D O I
10.1093/carcin/bgl111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies demonstrate that the covalent modification of thioredoxin reductase (TrxR) by both endogenous and exogenous electrophiles results in disruption of the conformation of the tumor suppressor protein p53. Here we report that the loss of normal cellular TrxR enzymatic activity by electrophilic modification or deletion of the C-terminal catalytic selenocysteine residue has functional consequences that are distinct from those resulting from depletion of TrxR protein in human RKO colon cancer cells. A thorough kinetic analysis was performed on purified TrxR in order to characterize the mechanism of its inhibition by electrophiles. Furthermore, electrospray mass spectrometry confirmed the alkylation of TrxR by lipid electrophiles and liquid chromatography-mass spectrometry/mass spectrometry identified the C-terminus as one target for alkylation. Then the consequences of TrxR modification by electrophiles on p53 conformation, transactivation and apoptosis were compared and contrasted with the effects of depletion of TrxR protein by treatment of cells with small interfering RNA directed against TrxR1. We found that cells depleted of TrxR were actually less sensitive to electrophile-induced disruption of p53 conformation and apoptosis than were cells expressing normal levels of TrxR. When RKO cells depleted of wild-type TrxR were transfected with C-terminal mutants of TrxR lacking the catalytic selenocysteine, p53 was found to be conformationally deranged, similar to cells treated with electrophiles. These results lead us to conclude that C-terminal modification of TrxR is both necessary and sufficient for the disruption of p53 and for the induction of apoptosis. Endogenous lipid electrophiles have been our primary focus; however, metabolic activation of hormones can generate endogenous mutagens, and we demonstrate that estrone-quinone attenuates p53 function in human MCF7 cells.
引用
收藏
页码:2538 / 2549
页数:12
相关论文
共 50 条
  • [21] p53: not just a tumor suppressor
    Oren, Moshe
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (07) : 539 - 543
  • [22] P53 TUMOR SUPPRESSOR GENE
    SOUSSI, T
    BULLETIN DU CANCER, 1993, 80 (02) : 96 - 101
  • [23] Hsf1 is required for the nuclear translocation of p53 tumor suppressor
    Li, Qiang
    Feldman, Rebecca A.
    Radhakrishnan, Vijayababu M.
    Carey, Steven
    Martinez, Jesse
    NEOPLASIA, 2008, 10 (10): : 1138 - 1145
  • [24] Tumor suppressor p53 is required to modulate BRCA1 expression
    Arizti, P
    Fang, L
    Park, I
    Yin, YX
    Solomon, E
    Ouchi, T
    Aaronson, SA
    Lee, SW
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) : 7450 - 7459
  • [25] p53 Binds to and Is Required for the Repression of Arf Tumor Suppressor by HDAC and Polycomb
    Zeng, Yaxue
    Kotake, Yojiro
    Pei, Xin-Hai
    Smith, Matthew D.
    Xiong, Yue
    CANCER RESEARCH, 2011, 71 (07) : 2781 - 2792
  • [26] The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration
    Di Giovanni, Simone
    Knights, Chad D.
    Rao, Mahadev
    Yakovlev, Alexander
    Beers, Jeannette
    Catania, Jason
    Avantaggiati, Maria Laura
    Faden, Alan I.
    EMBO JOURNAL, 2006, 25 (17): : 4084 - 4096
  • [27] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [28] Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells
    Ravi, D
    Muniyappa, H
    Das, KC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) : 40084 - 40096
  • [29] The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis
    McKay, BC
    Chen, F
    Perumalswami, CR
    Zhang, FF
    Ljungman, M
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (08) : 2543 - 2551
  • [30] Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene
    Jerry, DJ
    Dickinson, ES
    Roberts, AL
    Said, TK
    JOURNAL OF DAIRY SCIENCE, 2002, 85 (05) : 1103 - 1110